Compare Biogen Inc (BIIB) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Altria Group Inc — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Altria Group Inc trades at $65.04 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 3.6× Biogen Inc's market cap, and Altria Group Inc pays a 6.52% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | MO | |
|---|---|---|
Market Cap | $30.13B | $108.58B |
Sector | Health | Consumer Staples |
52-Week High | $216.63 | $74.92 |
52-Week Low | $128.93 | $54.72 |
Enterprise Value | $37.20B | $130.79B |
Dividend Yield | — | 6.52% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
